Geode Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9M Buy
790,138
+47,531
+6% +$1.71M ﹤0.01% 2004
2026
Q1
$26.3M Buy
742,607
+7,527
+1% +$306K ﹤0.01% 1846
2025
Q4
$29.8M Sell
735,080
-2,123
-0.3% -$92.4K ﹤0.01% 1791
2025
Q3
$34.7M Buy
737,203
+2,674
+0.4% +$139K ﹤0.01% 1703
2025
Q2
$38.3M Buy
734,529
+19,944
+3% +$1.09M ﹤0.01% 1572
2025
Q1
$43.2M Buy
714,585
+21,793
+3% +$1.4M ﹤0.01% 1463
2024
Q4
$47.4M Sell
692,792
-608
-0.1% -$42.4K ﹤0.01% 1465
2024
Q3
$49.9M Buy
693,400
+8,274
+1% +$584K ﹤0.01% 1426
2024
Q2
$47.5M Buy
685,126
+22,385
+3% +$1.63M ﹤0.01% 1391
2024
Q1
$53.1M Buy
662,741
+18,420
+3% +$1.64M ﹤0.01% 1312
2023
Q4
$70.6M Buy
644,321
+30,924
+5% +$3.2M 0.01% 1099
2023
Q3
$61.9M Buy
613,397
+24,753
+4% +$2.84M 0.01% 1086
2023
Q2
$80M Buy
588,644
+35,465
+6% +$4.33M 0.01% 935
2023
Q1
$57.5M Buy
553,179
+22,207
+4% +$2.15M 0.01% 1093
2022
Q4
$47.1M Buy
530,972
+18,261
+4% +$1.52M 0.01% 1191
2022
Q3
$41.1M Buy
512,711
+26,788
+6% +$2.53M 0.01% 1227
2022
Q2
$46.5M Sell
485,923
-7,053
-1% -$846K 0.01% 1183
2022
Q1
$73.2M Buy
492,976
+15,093
+3% +$2.11M 0.01% 968
2021
Q4
$67.7M Buy
477,883
+12,598
+3% +$1.78M 0.01% 1075
2021
Q3
$60.9M Sell
465,285
-8,349
-2% -$1.09M 0.01% 1109
2021
Q2
$65.1M Buy
473,634
+31,793
+7% +$4.35M 0.01% 1087
2021
Q1
$57.7M Buy
441,841
+32,608
+8% +$3.92M 0.01% 1118
2020
Q4
$45.8M Buy
409,233
+25,892
+7% +$2.45M 0.01% 1158
2020
Q3
$30.2M Sell
383,341
-11,576
-3% -$944K 0.01% 1229
2020
Q2
$28.4M Buy
394,917
+9,054
+2% +$630K 0.01% 1243
2020
Q1
$22.1M Buy
385,863
+4,117
+1% +$380K 0.01% 1228
2019
Q4
$42.7M Buy
381,746
+6,296
+2% +$671K 0.01% 1044
2019
Q3
$36.1M Buy
375,450
+2,584
+0.7% +$243K 0.01% 1077
2019
Q2
$31.9M Buy
372,866
+42,095
+13% +$3.46M 0.01% 1161
2019
Q1
$27.5M Buy
330,771
+34,005
+11% +$2.47M 0.01% 1202
2018
Q4
$19.1M Buy
296,766
+24,920
+9% +$1.71M 0.01% 1314
2018
Q3
$21.5M Buy
271,846
+10,528
+4% +$814K 0.01% 1357
2018
Q2
$19.1M Buy
261,318
+24,472
+10% +$1.66M 0.01% 1388
2018
Q1
$15M Buy
236,846
+5,421
+2% +$324K ﹤0.01% 1471
2017
Q4
$11.8M Buy
231,425
+2,206
+1% +$115K ﹤0.01% 1621
2017
Q3
$12M Buy
229,219
+4,961
+2% +$249K ﹤0.01% 1593
2017
Q2
$11.4M Buy
224,258
+12,716
+6% +$629K ﹤0.01% 1562
2017
Q1
$9.39M Buy
211,542
+17,834
+9% +$767K ﹤0.01% 1661
2016
Q4
$8.56M Buy
193,708
+6,422
+3% +$273K ﹤0.01% 1691
2016
Q3
$7.5M Buy
187,286
+3,386
+2% +$144K ﹤0.01% 1683
2016
Q2
$8.78M Buy
183,900
+2,600
+1% +$110K ﹤0.01% 1536
2016
Q1
$7.6K Buy
181,300
+3,522
+2% +$138K ﹤0.01% 1577
2015
Q4
$7.83M Sell
177,778
-1,084
-0.6% -$47K ﹤0.01% 1549
2015
Q3
$8.54M Buy
178,862
+4,613
+3% +$253K 0.01% 1450
2015
Q2
$10.2M Buy
174,249
+6,500
+4% +$350K 0.01% 1408
2015
Q1
$8.47M Buy
167,749
+14,104
+9% +$691K ﹤0.01% 1511
2014
Q4
$6.91M Buy
153,645
+1,952
+1% +$81.8K ﹤0.01% 1613
2014
Q3
$5.59M Buy
151,693
+7,246
+5% +$287K ﹤0.01% 1690
2014
Q2
$6.38M Sell
144,447
-6,898
-5% -$313K ﹤0.01% 1636
2014
Q1
$6.58M Buy
151,345
+3,068
+2% +$137K ﹤0.01% 1566
2013
Q4
$6.3M Sell
148,277
-12
-0% -$456 ﹤0.01% 1520
2013
Q3
$5.04M Buy
148,289
+1,578
+1% +$51.5K ﹤0.01% 1549
2013
Q2
$4.58M Buy
+146,711
New +$4.76M ﹤0.01% 1478

Other funds holding CNMD

Geode Capital Management's CNMD Position: Q2 2026 in Review

Geode Capital Management increased its CONMED (CNMD) stake by 6.4% in Q2 2026, buying an estimated $1.71M and bringing the position to 790,138 shares worth $25.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Geode Capital Management first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $80M in Q2 2023. 229 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Geode Capital Management held 790,138 shares of CONMED worth $25.9M as of Q2 2026.
  • Geode Capital Management bought 47,531 CONMED shares in Q2 2026, an estimated $1.71M.
  • CONMED made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2004 holding.
  • Geode Capital Management first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
  • Geode Capital Management's CONMED position peaked at $80M in Q2 2023.
  • 229 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.